XML 72 R62.htm IDEA: XBRL DOCUMENT v3.22.2.2
Net Loss Per Share Attributable to Adaptive Biotechnologies Corporation Common Shareholders - Computation of the Basic and Diluted Net Loss Per Share Attributable to Common Shareholders (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Earnings Per Share [Abstract]        
Net loss attributable to Adaptive Biotechnologies Corporation $ (45,281) $ (55,903) $ (160,063) $ (145,846)
Weighted-average shares used in computing net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders, basic 142,928,654 140,833,564 142,334,342 140,060,379
Net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders, basic $ (0.32) $ (0.40) $ (1.12) $ (1.04)
Weighted-average shares used in computing net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders, diluted 142,928,654 140,833,564 142,334,342 140,060,379
Net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders, diluted $ (0.32) $ (0.40) $ (1.12) $ (1.04)